Mepolizumab for the treatment of chronic rhinosinusitis with nasal polyps in adults.

Josh NeposlanLeigh J Sowerby Ameen Biadsee

Published in: Expert review of respiratory medicine (2023)

: Mepolizumab is an emerging biologic therapy that shows promising potential for the treatment of CRSwNP. It appears to provide both objective and subjective improvement as an addon therapy to standard of care treatment. Its specific role in treatment algorithms remains a topic of discussion. Future research surrounding its efficacy and cost effectiveness as compared to alternative options is needed.

Keyphrases

chronic rhinosinusitis
healthcare
risk assessment
depressive symptoms
combination therapy
deep learning
climate change
chronic pain
human health